
An analysis of national action plans (NAPs) on antimicrobial resistance (AMR) shows a "marked divide" in how high-income and low-income countries are able to respond to AMR, with low-income nations hampered by poor governance and systemic challenges, researchers reported yesterday in The Lancet Infectious Diseases.
For the analysis, a team of UK, US, and German researchers used a governance framework to assess 161 publicly available NAPs developed and implemented since 2017, when World Health Organization member states made a commitment to develop multisectoral NAPs using a One Health Approach. The framework consisted of 54 indicators pertaining to 18 domains that focus on three main areas relevant to global health governance: policy design, implementation tools, and monitoring and evaluation. A previous analysis by the same group in 2023 assessed 114 NAPs.
The researchers used national data from 2021-22 from five sources to generate composite scores for each country, ranked the countries by their mean score on a scale of 0 to 100, then evaluated the correlation between the country scores and various metrics on the burden of drug-resistant infections.
Higher governance scores linked to lower burden of AMR
Governance scores varied considerably across countries but were generally higher in high-income countries than low-income countries, indicating more effective and robust AMR control measures in countries with stronger economies, including the United States, United Kingdom, France, Sweden, and Denmark.
"The distribution of scores highlighted a trend whereby economic strength appeared closely aligned with both income levels and regional affiliation, emphasising a global inequality in antimicrobial resistance scores based on economic development," the study authors wrote. Countries with long-standing democratic traditions and more stable political environments also had higher scores.
In turn, higher governance scores were significantly associated with a lower burden of AMR-associated disability-adjusted life-years and death. Infection prevention and control, surveillance, and antimicrobial stewardship were the domains most strongly correlated with a lower burden of drug-resistant infections.
"These results should support policy makers to select priority actions for their respective action plans and to close the implementation gaps between countries and regions," the authors concluded.